The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
RX/reimbursement adult incontinence continued to benefit from rising awareness of the new and more automated reimbursement system in 2019. Sales also benefited from the stigma associated with urinary incontinence decreasing among the older population, owing to increased education levels in society, in addition to population ageing and ongoing urbanisation.
For much of the review period, players’ main focus in of distribution was specialist medical stores, with these stores attracting loyal customers by providing home delivery and reimbursements. However, the reimbursement system was fully automated at the end of 2017, with chemists/pharmacies becoming able to deduct reimbursement value at the point-of-sale.
Ontex continued to benefit from its exceptionally wide distribution network and its successful brand communication activities in 2019, with its Canped brand perceived as offering affordable products and adequate quality. Ontex thus continued to lead RX/reimbursement adult incontinence in 2019.
Sales of RX/reimbursement adult incontinence are expected to grow by 6% in 2019 constant value terms in 2020 overall in light of the impact of COVID-19.
Over the forecast period, it is predicted that RX/reimbursement adult incontinence will continue to gain volume share within overall adult incontinence sales, given increasing awareness of the convenience of the new on-site reimbursement system. In addition, ongoing urbanisation is leading to a more informed consumer base and reducing the stigma associated with incontinence, while also offering many easier access to these products.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Turkey with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Turkey, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Turkey market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.